01
Selective Funding Demands Clarity
With biotechnology funding becoming more selective, businesses must clearly articulate their value and scientific credibility to attract investment and secure market position.
Sector Insight
04 / 09
What we're seeing across Biotechnology
Our point of view
Four shifts shaping Biotechnology
04 / 04
02
Engagement is Key to Growth
Consistent customer engagement is no longer optional; it's essential for building pipeline and reducing reliance on referrals in a competitive funding landscape.
03
Technical Expertise Needs Commercial Support
Even with strong technical expertise and manufacturing, a robust commercial engine is vital to identify prospects and translate scientific evidence into buyer interest effectively.
04
Automate for Sustainable Pipeline
To scale without increasing manual resources, life sciences companies need to automate follow-up and pipeline generation, moving beyond traditional methods.
The Numbers
What the data is telling us
06 / 06
01
UK Life Sciences: Long-Term Opportunity
This indicates a stable and growing market, providing a strong foundation for ambitious SMEs to invest in and expand their operations with confidence.
02
2025
Biotechnology Funding Selective in 2025
This means SMEs must demonstrate exceptional value and scientific rigour to secure investment, making a compelling commercial narrative more important than ever.
03
Value and Credibility are Crucial
For SMEs, clearly communicating their unique value proposition and scientific backing will differentiate them in a competitive market and attract key stakeholders.
04
Consistent Customer Engagement
Maintaining regular, meaningful interactions with potential and existing customers will build trust, nurture leads, and drive sustained commercial growth for SMEs.
05
Reduce Reliance on Referrals
SMEs need to build proactive commercial strategies to generate new business, rather than solely depending on word-of-mouth, ensuring more predictable and scalable growth.
06
Build Pipeline Without Manual Resource
Implementing smart commercial tools allows SMEs to expand their sales pipeline efficiently, freeing up valuable human capital for higher-value activities and strategic initiatives.
Selected case studies
Outcomes we've delivered for similar businesses
Case study
UK-based biotechnology services company
Challenge
Nexus BioQuest faced fragmented data across multiple systems and manual processes, hindering efficiency. A tight deadline loomed as their legacy system subscription was expiring, necessitating urgent data migration.
What we delivered
Forbidden rapidly migrated data from Monday.com to HubSpot, ensuring continuity and zero downtime. They configured a tailored HubSpot Sales Hub with custom properties, streamlined pipelines, and core reporting dashboards.
Outcome
Nexus BioQuest achieved a unified, high-performing CRM environment within four weeks, with zero data loss. The team now operates efficiently within HubSpot, utilising standardised sales tools and robust reporting capabilities.